{"abstract": "Amgen is exercising an option to acquire the rights to an experimental drug to treat heart failure from Cytokinetics, a smaller biotechnology company.", "web_url": "https://dealbook.nytimes.com/2009/05/26/amgen-acquires-rights-to-new-heart-drug/", "snippet": "Amgen is exercising an option to acquire the rights to an experimental drug to treat heart failure from Cytokinetics, a smaller biotechnology company.", "lead_paragraph": "Amgen is exercising an option to acquire the rights to an experimental drug to treat heart failure from Cytokinetics, a smaller biotechnology company, The New York Times\u2019s Andrew Pollack reported.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Amgen Acquires Rights to New Heart Drug", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [], "pub_date": "2009-05-26T11:24:35+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Dealbook", "person": [{"firstname": "Dealbook", "middlename": null, "lastname": "", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/f8ff4e37-582c-5828-bcb4-efe4e28187c3", "word_count": 174, "uri": "nyt://article/f8ff4e37-582c-5828-bcb4-efe4e28187c3"}